IN-VITRO METHOD FOR DETERMINING INCREASED RISK OF AN APPARENTLY HEALTHY SUBJECT FOR SUFFERING FROM ADVERSE EVENTS

摘要

pThe present invention relates to an in vitro method for the prognosis of an adverse event in asymptomatic subjects comprising the determination of the level of Procalcitonin (PCT) or a fragment thereof or a precursor or fragment thereof having at least 12 amino acid residues in a sample of a bodily fluid from said subject and the correlation of the determined level to a potential risk of sustaining an adverse event./p[WO2011023813A1]